These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6926 related articles for article (PubMed ID: 2654956)

  • 21. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
    Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
    Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model.
    Ruf P; Schäfer B; Eissler N; Mocikat R; Hess J; Plöscher M; Wosch S; Suckstorff I; Zehetmeier C; Lindhofer H
    J Transl Med; 2012 Nov; 10():219. PubMed ID: 23134699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
    Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
    Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen.
    Yan X; Evans SV; Kaminki MJ; Gillies SD; Reisfeld RA; Houghton AN; Chapman PB
    J Immunol; 1996 Aug; 157(4):1582-8. PubMed ID: 8759742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isolation and analysis of monoclonal antibodies against various gangliosides].
    Fuks BB; Avrova NF; Van'ko LV; Starosvetskaia NA; Boltovskaia MN
    Biull Eksp Biol Med; 1986 Jan; 101(1):66-8. PubMed ID: 3942818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity.
    Thurin J; Thurin M; Kimoto Y; Herlyn M; Lubeck MD; Elder DE; Smereczynska M; Karlsson KA; Clark WM; Steplewski Z
    Cancer Res; 1987 Mar; 47(5):1229-33. PubMed ID: 3815333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside.
    Chapman PB; Williams L; Salibi N; Hwu WJ; Krown SE; Livingston PO
    Vaccine; 2004 Jul; 22(21-22):2904-9. PubMed ID: 15246627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody.
    Dippold WG; Knuth A; Meyer zum Büschenfelde KH
    Cancer Res; 1984 Feb; 44(2):806-10. PubMed ID: 6362854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3.
    Hersey P; Schibeci SD; Townsend P; Burns C; Cheresh DA
    Cancer Res; 1986 Dec; 46(12 Pt 1):6083-90. PubMed ID: 3022915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine.
    Milner RJ; Salute M; Crawford C; Abbot JR; Farese J
    Vet Immunol Immunopathol; 2006 Dec; 114(3-4):273-84. PubMed ID: 17027091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An IgG3 monoclonal antibody established after immunization with GM3 lactone: immunochemical specificity and inhibition of melanoma cell growth in vitro and in vivo.
    Dohi T; Nores G; Hakomori S
    Cancer Res; 1988 Oct; 48(20):5680-5. PubMed ID: 3167827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gangliosides, Ab1 and Ab2 antibodies IV. Dominance of VH domain in the induction of anti-idiotypic antibodies by gene gun immunization.
    López-Requena A; Mateo de Acosta C; Bestagno M; Vázquez AM; Pérez R; Burrone OR
    Mol Immunol; 2007 Apr; 44(11):3070-5. PubMed ID: 17337302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis.
    Cheresh DA; Honsik CJ; Staffileno LK; Jung G; Reisfeld RA
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5155-9. PubMed ID: 3860849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues.
    Dippold WG; Dienes HP; Knuth A; Meyer zum Büschenfelde KH
    Cancer Res; 1985 Aug; 45(8):3699-705. PubMed ID: 3893688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
    Houghton AN; Mintzer D; Cordon-Cardo C; Welt S; Fliegel B; Vadhan S; Carswell E; Melamed MR; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1242-6. PubMed ID: 3883355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
    George AJ; Tutt AL; Stevenson FK
    J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2.
    Berinstein N; Levy R
    J Immunol; 1987 Aug; 139(3):971-6. PubMed ID: 3496394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
    Nelson KA; George E; Swenson C; Forstrom JW; Hellström KE
    J Immunol; 1987 Sep; 139(6):2110-7. PubMed ID: 2957449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunohistological study of the mechanism of cytotoxic effect against cutaneous metastatic malignant melanoma by intralesional injection with anti-monosialoganglioside mouse monoclonal antibody (MAb 202)].
    Ota T; Imamura T; Hamanaka S; Nishioka K; Tai T; Kawashima I; Irie RF; Asagami C
    Nihon Hifuka Gakkai Zasshi; 1988 Aug; 98(9):913-22. PubMed ID: 3244169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 347.